Added to YB: 2019-05-16
Pitch date: 2019-05-16
RVX:CN [bullish]
Resverlogix Corp.
-96.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.
Market Cap
CAD 9.8M
Pitch Price
CAD 3.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
-22.42
P/E
-0.85
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
RESVERLOGIX CORP COM RVX:CN
A summary for this pitch has not been created yet.
Read full article (0 min)